These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 6709836)

  • 1. [Behavior and biological action of 239Pu administered intramuscularly during complexon therapy].
    Bazhin AG; Liubchanskiĭ ER; Nifatov AP; Siniakov EG
    Radiobiologiia; 1984; 24(1):129-32. PubMed ID: 6709836
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effect of combination of chelating agents on the translocation of intramuscularly depostied 239Pu nitrate in the rat.
    Volf V
    Health Phys; 1975 Jul; 29(1):61-8. PubMed ID: 1150463
    [No Abstract]   [Full Text] [Related]  

  • 3. [Biological action of 239Pu during intake by inhalation and complexon therapy with Zn or Ca DTPA under experimental conditions].
    Siniakov EG; Nifatov AP; Liubchanskiĭ ER; Bazhin AG
    Med Radiol (Mosk); 1988 May; 33(5):58-61. PubMed ID: 3374306
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Effect of Na3Zn- and Na3Ca-DTPA on the behavior and biological action of 239Pu on rats].
    Liubchanskiĭ ER; Nifatov AP; Okolelova NM; Siniakov EG
    Med Radiol (Mosk); 1985 Feb; 30(2):35-9. PubMed ID: 3918236
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [238Pu body distribution in dogs after intravenous administration and early complexon therapy].
    Sokhranich AL; Liubchanskiĭ ER
    Med Radiol (Mosk); 1990 Jul; 35(7):41-3. PubMed ID: 2197521
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bone sarcomas in 239Pu-treated mice.
    Svoboda V; Klener V; Bubeníková D; Globocnik E
    Neoplasma; 1980; 27(1):3-10. PubMed ID: 6929411
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The wound clearance and distribution of plutonium, americium and curium in rodents.
    Harrison JD; David AJ; Stather JW
    Int J Radiat Biol Relat Stud Phys Chem Med; 1980 May; 37(5):505-12. PubMed ID: 6967464
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy of orally administered amphipathic polyaminocarboxylic acid chelators for the removal of plutonium and americium: comparison with injected Zn-DTPA in the rat.
    Miller SC; Liu G; Bruenger FW; Lloyd RD
    Radiat Prot Dosimetry; 2006; 118(4):412-20. PubMed ID: 16332916
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Retention of plutonium in the beagle after gastrointestinal absorption.
    Toohey RE; Bhattacharyya MH; Oldham RD; Larsen RP; Moretti ES
    Radiat Res; 1984 Feb; 97(2):373-9. PubMed ID: 6695054
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Metabolic kinetics and the biological action of 238Pu in the body of rabbits after intratracheal administration].
    Zalikin GA; Nisimov PG
    Radiobiologiia; 1987; 27(2):267-70. PubMed ID: 3575674
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Distribution and toxicity of monomeric and polymeric 239Pu in immature and adult rats.
    Mahlum DD; Sikov MR
    Radiat Res; 1974 Oct; 60(1):75-88. PubMed ID: 10881701
    [No Abstract]   [Full Text] [Related]  

  • 12. Effect of dose level on skeletal retention of 239Pu(IV) in the beagle.
    Stover BJ; Atherton DR; Stevens W; Buster DS; Bruenger FW
    Radiat Res; 1977 Mar; 69(3):442-58. PubMed ID: 847096
    [No Abstract]   [Full Text] [Related]  

  • 13. Duration and dose-related effects of an orally administered, partially lipophilic polyaminocarboxylic acid on the decorporation of plutonium and americium.
    Miller SC; Bruenger FW; Kuswik-Rabiega G; Liu G; Lloyd RD
    J Pharmacol Exp Ther; 1993 Oct; 267(1):548-54. PubMed ID: 8229785
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Evaluation of changes in the median life span of animals following separate and combined exposures to external 137Cs gamma irradiation and incorporated 239Pu].
    Levdik TI; Buldakov LA; Dement'ev SI
    Radiobiologiia; 1989; 29(4):550-3. PubMed ID: 2780989
    [No Abstract]   [Full Text] [Related]  

  • 15. [Long-term effects of combined exposure to external 137Cs gamma-radiation and incorporated 239Pu].
    Buldakov LA; Levdik TI
    Radiobiologiia; 1984; 24(5):668-71. PubMed ID: 6390500
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Incidence of plutonium-induced bone cancer in neutered mice.
    Taylor GN; Gardner P; Mays CW; Wrenn ME; Charrier K
    Cancer Res; 1981 Mar; 41(3):971-3. PubMed ID: 7459884
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Biological effects of the intramuscular administration of 239Pu as affected by chelate therapy].
    Siniakov EG; Nifatov AP; Bazhin AG; Liubchanskiĭ ER
    Med Radiol (Mosk); 1988 Mar; 33(3):60-3. PubMed ID: 3352497
    [No Abstract]   [Full Text] [Related]  

  • 18. [Removal of monomeric 239Pu from bones and liver by liposome-encapsulated pentacin].
    Smirnov AA; Beliaev IK; Ivannikov AT; Il'in LA
    Biull Eksp Biol Med; 1985 Oct; 100(10):431-3. PubMed ID: 4052611
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The distribution of intratracheally administered plutonium-239 throughout the skeletal bones].
    Rushonik SI; Ivanova NP; Shvydko NS
    Radiobiologiia; 1992; 32(4):608-11. PubMed ID: 1410299
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reducing the cancer risk of 239Pu by chelation therapy.
    Jones CW; Mays CW; Taylor GN; Lloyd RD; Packer SM
    Radiat Res; 1986 Sep; 107(3):296-306. PubMed ID: 3749464
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.